Campu v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
Gary Campu |
Chattem, Inc., Sanofi US Services Inc., Pfizer, Inc., GlaxoSmithKline, LLC and Boehringer Ingelheim Pharmaceuticals, Inc. |
2:2019cv02380 |
November 25, 2019 |
US District Court for the Eastern District of California |
Edmund F Brennan |
Kimberly J Mueller |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on February 21, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 16 MINUTE ORDER issued by Courtroom Deputy C. Schultz for Chief District Judge Kimberly J. Mueller GRANTING Defendant's Proposed Substitution of Attorney (ECF No. #14 ). Attorney Mark A. Sentenac is SUBSTITUTED as counsel of record for Defendant Boehringer Ingelheim Pharmaceuticals, Inc. in place of Attorney Lindsey C. Barnhart. (Text Only Entry)(Schultz, C) |
Filing 15 MOTION to DISMISS by Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services Inc.. Attorney Kas-Osoka, Oluoma Nkechinyere added. Motion Hearing set for 3/6/2020 at 10:00 AM in Courtroom 3 (KJM) before Chief District Judge Kimberly J. Mueller. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Kas-Osoka, Oluoma) Modified on 1/23/2020 (Kaminski, H). |
Filing 14 SUBSTITUTION of ATTORNEY - PROPOSED, submitted by Boehringer Ingelheim Pharmaceuticals, Inc.. (Barnhart, Lindsey) |
Filing 13 MINUTE ORDER: Having reviewed the parties stipulation (ECF No. #12 ) and good cause appearing, defendants Motion to Stay Proceedings (ECF No. #4 ) is hereby SUBMITTED for decision on the briefs on file. The hearing set for January 17, 2020 is VACATED. (TEXT ONLY ENTRY)(Souvannarath, A) |
Filing 12 STIPULATION and PROPOSED ORDER re Waiver of Oral Argument on Defendants' #5 Motion to Stay by Boehringer Ingelheim Pharmaceuticals, Inc., et al., (Attachments: #1 Proposed Order)(Barnhart, Lindsey) Modified on 1/14/2020 (Benson, A.). |
Filing 11 REPLY by Boehringer Ingelheim Pharmaceuticals, Inc., et al., in support of #4 Motion to Stay. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Barnhart, Lindsey) Modified on 1/14/2020 (Benson, A.). |
Filing 10 OPPOSITION by Gary Campu to #4 Motion to Stay. (Moore, Jennifer) |
Filing 9 CORPORATE DISCLOSURE STATEMENT by Defendant Chattem, Inc.. (Kas-Osoka, Oluoma) |
Filing 8 CORPORATE DISCLOSURE STATEMENT by Defendant Sanofi US Services Inc.. (Kas-Osoka, Oluoma) |
Filing 7 MINUTE ORDER issued by Relief Courtroom Deputy G. Michel for District Judge Kimberly J. Mueller on 12/12/2019: Having considered Defendants' #5 Ex Parte Application for Extension of Time, the court GRANTS Defendants' Application and ORDERS that Defendants respond to Plaintiff's Complaint by 1/22/2020. (TEXT ONLY) (Michel, G.) |
Filing 6 CORPORATE DISCLOSURE STATEMENT by Defendant Boehringer Ingelheim Pharmaceuticals, Inc.. (Barnhart, Lindsey) |
Filing 5 EX PARTE APPLICATION for Extension of Time to Respond to Complaint by Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services Inc.. (Attachments: #1 Affidavit, #2 Proposed Order)(Barnhart, Lindsey) Modified on 12/11/2019 (Kaminski, H). |
Filing 4 MOTION to STAY by Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services Inc.. Attorney Barnhart, Lindsey Catherine added. Motion Hearing set for 1/17/2020 at 10:00 AM in Courtroom 3 (KJM) before District Judge Kimberly J. Mueller. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Proposed Order)(Barnhart, Lindsey) Modified on 12/11/2019 (Kaminski, H). |
Filing 3 CIVIL NEW CASE DOCUMENTS ISSUED; Initial Scheduling Conference set for 4/2/2020 at 02:30 PM in Courtroom 3 (KJM) before District Judge Kimberly J. Mueller. (Attachments: #1 Standing Order, #2 Consent Form, #3 VDRP) (Benson, A.) |
Filing 2 SUMMONS ISSUED as to *Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services Inc.* with answer to complaint due within *21* days. Attorney *Jennifer Ann Moore* *Moore Law Group, PLLC* *1473 S. 4th St., 4th Street* *Louisville, KY 40208*. (Benson, A.) |
Filing 1 COMPLAINT against all Defendants by Gary Campu. Attorney Moore, Jennifer Ann added. (Filing fee $ 400, receipt number 0972-8589667) (Attachments: #1 Civil Cover Sheet)(Moore, Jennifer) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.